Osaic Holdings’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
Other funds holding PDSB
VCM
VFT
IWA
AC
Osaic Holdings's PDSB Position: Q1 2026 in Review
Osaic Holdings sold out of PDS Biotechnology (PDSB) in Q1 2026, closing a stake of 17 shares — an estimated $13 sold.
Osaic Holdings first reported a position in PDSB in Q1 2020 and held it in 24 quarters. The position peaked at $32K in Q2 2021. 41 funds tracked by Wall St. Rank hold PDSB as of Q1 2026.
- Osaic Holdings reported no remaining PDS Biotechnology position as of Q1 2026 after selling out during the quarter.
- Osaic Holdings sold 17 PDS Biotechnology shares in Q1 2026, an estimated $13.
- Osaic Holdings first reported a position in PDS Biotechnology in Q1 2020 and held it in 24 quarters.
- Osaic Holdings's PDS Biotechnology position peaked at $32K in Q2 2021.
- 41 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2026.
Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.